BSE Live
Jan 23, 09:32Prev. Close
768.55
Open Price
773.95
Bid Price (Qty.)
766.80 (13)
Offer Price (Qty.)
768.30 (13)
NSE Live
Jan 23, 09:32Prev. Close
769.40
Open Price
768.80
Bid Price (Qty.)
767.15 (7)
Offer Price (Qty.)
768.00 (12)
| Cash Flow of Alembic Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,166.79 | 764.63 | 535.22 | 549.71 | 913.31 | |
| Net CashFlow From Operating Activities | 539.75 | 808.80 | 304.55 | 320.61 | 847.53 | |
| Net Cash Used In Investing Activities | -822.31 | -753.59 | -793.58 | -504.54 | -293.07 | |
| Net Cash Used From Financing Activities | 166.13 | 79.67 | 497.79 | -95.95 | -274.05 | |
| Foreign Exchange Gains / Losses | 0.41 | -0.07 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -116.02 | 134.81 | 8.76 | -279.88 | 280.41 | |
| Cash And Cash Equivalents Begin of Year | 144.24 | 9.45 | 0.69 | 280.56 | 4.40 | |
| Cash And Cash Equivalents End Of Year | 28.22 | 144.26 | 9.45 | 0.68 | 284.81 |
17.11.2025
Alembic Pharma shares gain 2% on USFDA nod for Diltiazem Hydrochloride tablets
17.11.2025
10.11.2025
Alembic Pharma Standalone September 2025 Net Sales at Rs 1,796.24 crore, up 13.66% Y-o-Y
07.11.2025
Alembic Pharma Consolidated September 2025 Net Sales at Rs 1,910.15 crore, up 15.91% Y-o-Y
10.11.2025
Alembic Pharma Standalone September 2025 Net Sales at Rs 1,796.24 crore, up 13.66% Y-o-Y
07.11.2025
Alembic Pharma Consolidated September 2025 Net Sales at Rs 1,910.15 crore, up 15.91% Y-o-Y
12.08.2025
Alembic Pharma Consolidated June 2025 Net Sales at Rs 1,710.72 crore, up 9.54% Y-o-Y
05.08.2025
Alembic Pharma Standalone June 2025 Net Sales at Rs 1,494.17 crore, up 1.26% Y-o-Y
19.10.2021
Alembic Pharma Q2 PAT may dip 49.2% YoY to Rs 169.4 cr: ICICI Direct
13.07.2021
Alembic Pharmaceuticals Q1 PAT may dip 28.7% YoY to Rs 215 cr: KRChoksey
12.07.2021
Alembic Pharma Q1 PAT may dip 20.3% YoY to Rs 240.2 cr: ICICI Direct
18.01.2021
Alembic Pha Q3 PAT seen up 19.9% YoY to Rs. 280.9 cr: ICICI Direct